The Gene Polymorphism of LOX1 Predicts the Incidence of LVH in Patients with Essential Hypertension | Zendy

Xiaolin Xu | Zendy; Xuwei Hou | Zendy; Yixiu Liang | Zendy; Li Fan | Zendy; Liewen Pang | Zendy; Guoqian Huang | Zendy; Jiechun Huang | Zendy; Meng Shi | Zendy; Xiaotian Sun | Zendy; Yiqing Wang | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

The Gene Polymorphism of LOX1 Predicts the Incidence of LVH in Patients with Essential Hypertension

Author(s) -

Xiaolin Xu,

Xuwei Hou,

Yixiu Liang,

Li Fan,

Liewen Pang,

Guoqian Huang,

Jiechun Huang,

Meng Shi,

Xiaotian Sun,

Yiqing Wang

Publication year - 2014

Publication title -

cellular physiology and biochemistry

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.486

H-Index - 87

eISSN - 1421-9778

pISSN - 1015-8987

DOI - 10.1159/000356652

Subject(s) - left ventricular hypertrophy , single nucleotide polymorphism , medicine , genotype , snp , polymorphism (computer science) , cardiology , essential hypertension , gene polymorphism , endocrinology , biology , gene , blood pressure , genetics

Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) has been shown to play an important role in cardiac remodeling under different pathologic conditions. The role of genetic polymorphisms in the LOX1 gene, however, remains unclear in the development of left ventricular hypertrophy (LVH) for patients with hypertension.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research